Abdominal Pain Location Guide: Causes, Red Flags and Appropriate Imaging
Abdominal pain by location: appendicitis, gallstones, pancreatitis, ectopic pregnancy, diverticulitis and urgent signs, with ACR guidance on CT, ultrasound and MRI.
Abdominal pain by location: appendicitis, gallstones, pancreatitis, ectopic pregnancy, diverticulitis and urgent signs, with ACR guidance on CT, ultrasound and MRI.
Chest pain guide covering heart attack warning signs, pulmonary embolism, aortic dissection, 2025 ACS ECG within 10 minutes, serial troponin, aspirin/nitrate safety and urgent care.
Evidence-based persistent fatigue guide covering anemia, sleep apnea, diabetes and thyroid problems, ME/CFS and post-exertional malaise, CDC pacing guidance and when to seek care.
Chronic headaches guide incorporating 2026 AAN/AHS migraine prevention, chronic migraine criteria, CGRP medicines, topiramate, onabotulinumtoxinA, medication-overuse safety and red flags.
Androgen pharmacology: receptor mechanisms, testosterone metabolism and formulations, endocrine feedback, infertility and AAS risks, TRAVERSE, FDA 2025–2026 updates and monitoring.
Antiemetic drug classes and mechanisms: 5-HT3, D2, H1, NK1 and M1 receptors; CINV prevention, 2025 AGA gastroparesis guidance, pregnancy nausea, QT and movement-disorder risks.
Evidence-based vitamins and nutraceuticals: B12, vitamin D, B6, folic acid in pregnancy, omega-3, biotin lab interference, herbal interactions and supplement safety.
Gene therapy mechanisms and FDA products: AAV, lentiviral and CRISPR cell therapy, Casgevy, Zolgensma GLI1 cancer safety alert, Elevidys liver warnings and long-term monitoring.
Evidence-based ophthalmic pharmacology: prostaglandin analogues, timolol, 2026 AAO glaucoma recommendations, steroid risks, dry eye treatments, retinal anti-VEGF and eye-drop technique.
Dermatological drugs: topical steroid potency, eczema calcineurin/PDE4/JAK treatments, 2025 AAD biologics, acne antibiotic stewardship, psoriasis immunomodulators and antifungal therapy.